Flector Patch and ZTlido: Brand Topical Pain Medications for Personal Injury Patients

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | November 28, 2024 | 8 min read

Topical pain medications deliver drug directly to the injury site through the skin, providing localized relief with minimal systemic exposure. The Flector Patch (diclofenac) and ZTlido (lidocaine 1.8%) are two brand-name topical options increasingly prescribed for personal injury patients with localized musculoskeletal and neuropathic pain.

Flector Patch and ZTlido: Brand Topical Pain Medications for Personal Injury Patients

Topical pain medications occupy a specific and important niche in personal injury treatment. Unlike oral medications that distribute throughout the body and require systemic metabolism, topical agents are applied directly over the injured area and deliver drug through the skin to the underlying tissue — providing localized action with substantially reduced systemic drug exposure.

For personal injury patients, this means effective localized pain control with fewer systemic side effects, making topicals an appropriate long-term component of treatment even when oral anti-inflammatory medications would be concerning for prolonged use. Two brand-name topical options — the Flector Patch and ZTlido — address different aspects of localized PI pain and are increasingly common in personal injury pharmacy regimens.

The Flector Patch (Diclofenac Epolamine)

What It Is

The Flector Patch is a prescription transdermal patch containing diclofenac epolamine 1.3%. Diclofenac is an NSAID (non-steroidal anti-inflammatory drug), and in patch form it delivers anti-inflammatory medication directly to the painful area through the skin.

The patch was developed to address a clinical problem: while oral diclofenac effectively treats inflammation, oral NSAIDs require systemic absorption that exposes the entire body — including the gastrointestinal tract — to the drug. In PI patients who need sustained anti-inflammatory treatment, prolonged oral NSAID use increases GI risk substantially. The Flector Patch delivers therapeutic drug concentrations to the local tissue with systemic exposure roughly 10-fold lower than equivalent oral dosing, dramatically reducing GI and renal concerns.

How It's Used

The Flector Patch is applied directly over the painful area twice daily — morning and evening — and left in place for approximately 12 hours per application. It is applied to intact skin over the injured site: the shoulder, knee, lower back, neck, or ankle depending on injury location.

Each patch maintains local drug concentrations at the application site over the 12-hour wear period, providing sustained localized anti-inflammatory effect rather than the peak-and-trough pharmacokinetics of oral dosing.

Best-Suited PI Injuries

• Whiplash with cervical inflammation — Applied over the posterior neck and cervical musculature
• Rotator cuff injuries — Applied over the shoulder
• Ankle and foot injuries — Applied over the affected joint
• Knee injuries — Applied over the patellar/joint area
• Lower back soft tissue injuries — Applied over the lumbar region

Any personal injury with a localized area of ongoing inflammation that would benefit from sustained topical NSAID treatment is a candidate for the Flector Patch.

Flector Patch vs. Generic Diclofenac Patches

The Flector Patch uses the epolamine salt form of diclofenac, which has specific penetration and solubility characteristics suited to the transdermal delivery system. While generic diclofenac gel and solution exist, the specific patch formulation of the Flector Patch involves proprietary delivery technology. The brand patch is prescribed when the physician requires the specific pharmacokinetics and patient adherence benefits of a patch system over a gel or solution.

ZTlido (Lidocaine 1.8% Topical System)

What It Is

ZTlido is a brand-name lidocaine topical system containing 1.8% lidocaine, FDA-approved for the relief of pain associated with post-herpetic neuralgia and more broadly used for neuropathic pain. It is a topical patch that delivers lidocaine — a local anesthetic and sodium channel blocker — through the skin to the underlying painful nerve tissue.

The key distinction between ZTlido and generic lidocaine patches (which are typically 5% lidocaine) is the formulation technology. ZTlido uses a proprietary hydrogel delivery system with a lower lidocaine concentration (1.8% vs. 5%) that achieves comparable or superior drug delivery to the target tissue due to its optimized penetration characteristics, while using significantly less total drug and producing lower systemic lidocaine levels.

How Topical Lidocaine Works for Neuropathic Pain

Neuropathic pain — burning, tingling, electric sensations, or allodynia (pain from light touch) — results from abnormal sodium channel activity in damaged peripheral nerve fibers. These injured nerves fire spontaneously, generating pain signals in the absence of ongoing injury stimulus.

Topical lidocaine blocks sodium channels in the skin and subcutaneous nerve fibers at the application site, reducing the spontaneous firing of damaged nociceptors. It does not cause anesthesia (numbness) at therapeutic doses — it attenuates the abnormal pain signals while preserving normal sensation.

Best-Suited PI Injuries

ZTlido is appropriate for personal injury patients with localized neuropathic pain — specifically areas of:

• Nerve entrapment or compression — From disc herniation affecting a specific dermatomal area
• Direct nerve trauma — Contusion or laceration of a peripheral nerve
• CRPS (Complex Regional Pain Syndrome) — Where localized allodynia and burning are prominent features
• Post-incision/post-surgical neuropathic pain — For patients who have undergone PI-related surgery
• Cervical or lumbar radiculopathy — Applied over the affected dermatome

ZTlido vs. Generic 5% Lidocaine Patches

Generic 5% lidocaine patches (OTC and prescription versions) deliver substantially higher total drug load per patch. ZTlido's 1.8% formulation in its hydrogel system achieves efficacious tissue concentrations with lower total drug burden, reducing the concern for systemic lidocaine accumulation during continuous use — a meaningful clinical advantage for patients needing long-term neuropathic pain management.

Why Topical Medications Matter in PI Cases

Lower Side Effect Profile Enables Longer Treatment

Personal injury recovery often requires sustained pain management over months. Oral NSAIDs and opioids carry dose-dependent risks that accumulate with prolonged use — GI bleeding for NSAIDs, dependence for opioids. Topical agents allow effective treatment to continue for months without escalating systemic risk, which is directly relevant to PI cases that extend over extended treatment periods.

Localized Application Documents Injury Location

The specific body location where a topical patch is applied is documented in prescribing instructions and clinical notes. A prescription for Flector Patch "apply to left shoulder twice daily" documents localized left shoulder pathology. This localization adds specificity to the injury documentation that oral medications — which are systemic — cannot provide.

Combination with Oral Medications

Topical agents are almost always prescribed alongside, not instead of, oral medications. A patient with lumbar disc injury may receive:

• Celebrex (oral COX-2 inhibitor for systemic inflammation)
• Flector Patch (localized topical NSAID over the lumbar area)
• Horizant (oral gabapentinoid for nerve root pain)

Each addresses a different aspect of the injury — the topical does not make the oral redundant; they target the same condition through different mechanisms and delivery routes.

Brand Documentation Supports Lien Value

Both the Flector Patch and ZTlido are brand-name products with no direct generic equivalent in their specific formulation. Generic diclofenac gel and generic lidocaine patches exist, but the specific patch/system formulation technology of these branded products is not generically replicated. Prescribers who choose Flector Patch or ZTlido over generic alternatives are making a specific clinical judgment that the proprietary delivery system is warranted — a clinical decision that is documented in the prescription.

What Attorneys Should Know

Patch Prescriptions Indicate Ongoing Localized Pathology

A prescription for Flector Patch or ZTlido applied to a specific location every day for three months represents 90 days of documented, localized, treated pathology at that site. The prescriber has assessed ongoing inflammation or neuropathic pain sufficient to warrant daily topical therapy.

These Are Not OTC Products

Both Flector Patch and ZTlido are prescription products, not over-the-counter. The prescription requirement means a physician made a clinical determination that these medications are medically necessary — not self-directed patient decisions.

[!KEY] Because Flector Patch and ZTlido are prescription-only, their presence in the pharmacy record reflects an independent physician determination of medical necessity — a direct counter to any defense argument that the patient was self-directing or overstating their treatment needs.

Patch Compliance Creates a Daily Record

Patients who use patches daily generate refill records on a predictable schedule. A Flector Patch prescription for twice-daily use produces a refill every 15-30 days, creating regular documentation intervals throughout the treatment period.

[!KEY] A Flector Patch prescription specifying "apply to left shoulder twice daily" creates anatomically specific injury documentation that systemic oral medications cannot replicate — the application site in the prescribing instructions directly maps the treated pathology to the claimed injury location.

[!KEY] The predictable refill cycle of topical patches — every 15 to 30 days — creates a regular, uninterrupted documentation trail throughout the treatment period. This rhythm of fills is a built-in counter to any defense argument that the patient's pain resolved between documented clinical visits.

Conclusion

Topical medications like the Flector Patch and ZTlido fill an important role in personal injury treatment: they provide localized, sustained relief for inflammation and neuropathic pain at the injury site with a side effect profile that supports long-term use. For attorneys, they add specificity to the injury documentation record — localized prescriptions for localized pathology at the anatomical site of injury.

For lien-based pharmacy coverage of Flector Patch, ZTlido, and other topical prescription medications, LienScripts provides pharmacy services for personal injury patients.

Related Resources

• Why PI Patients Often Need Multiple Medications
• Soft Tissue Injury Medications
• Nerve Damage After a Car Accident: Neuropathic Pain Medications
• Gabapentin for Whiplash: What Patients and Attorneys Need to Know